Synageva Biopharma (GEVA) more than doubles as Alexion buys

Synageva Biopharma Corp GEVA shares surged 116% to $207.06 after Alexion Pharmaceuticals, Inc. announced its plans to acquire Synageva for $8.4 billion. Share volume was 7.7 million, dwarfing an all-day average of 317,000
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!